6 terminated. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Terminated 6 |
Follow Low Back Pain: new trials by email Literature Review of Low Back Pain trials Research Report on Low Back Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short Terms Effects of Medial Branch Block vs Para-spinal Muscle Injection in Patients With Non-specific CLBP Medial branch block in one side, paravertebral deep intramuscular (PDI) injection - Low Back Pain, Mechanical | Phase 3 | Terminated | McGill University Health Centre/Research Institute of the McGill University Health Centre | 8 | 2014-08-25 | 2026-10-26 |
| Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability Tapentadol Prolonged Release - Pain, Chronic Pain | Phase 3 | Terminated | Grünenthal GmbH | 136 | 2009-10-30 | 2019-01-09 |
| Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy Usual Care, Early Treatment - Back Pain, Low Back Pain | Phase 3 | Terminated | Intermountain Health Care, Inc. | 15 | 2008-09-01 | 2011-07-18 |
| Work Related Rehabilitation in Patients With Low Back Pain work related rehabilitation - Low Back Pain | Phase 3 | Terminated | Ullevaal University Hospital | 260 | 2008-01-01 | 2011-07-06 |
| Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 Buprenorphine transdermal patch - Back Pain Lower Back Chronic | Phase 3 | Terminated | Purdue Pharma LP | 354 | 2004-06-01 | 2012-09-03 |
| Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain Buprenorphine, Oxycodone Immediate-Release - Back Pain Lower Back Chronic | Phase 3 | Terminated | Purdue Pharma LP | 660 | 2004-02-01 | 2012-09-03 |
Back Pain (1) · Chronic Pain (1) · Neuralgia (1) · Nociceptive Pain (1) · Pain (1)
Neurologic Manifestations (6) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Back Pain (5) · Pain (5) · Nervous System Diseases (1) · Neuromuscular Diseases (1) · Peripheral Nervous System Diseases (1)
Buprenorphine (2) · Injections (1) · Tapentadol (1)
Purdue Pharma LP (2) · Grünenthal GmbH (1) · Intermountain Health Care, Inc. (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Ullevaal University Hospital (1)
United States (3) · Belgium (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Netherlands (1) · Norway (1) · Poland (1) · Spain (1) · Switzerland (1)
Anne Keller, Dr.Med.Sc (1) · Deborah L Steiner, MD, MS (1) · Gerard P Brennan, PhD, PT (1) · Julie M Fritz, PhD,PT,ATC (1) · Martin Hale, MD (1)
2009 (1)